The evolution of diverse biological responses to DNA damage: insights from yeast and p53 (original) (raw)

• Lowndes, N. F. & Murguia, J. R. Sensing and responding to DNA damage. Curr. Opin. Genet. Dev. 10, 17–25 (2000).
  CAS PubMed Google Scholar
• Hartwell, L. H. & Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629–634 (1989).
  CAS PubMed Google Scholar
• Al-Khodairy, F. et al. Identification and characterisation of new elements involved in checkpoints and feedback controls in fission yeast. Mol. Biol. Cell 5, 147–160 (1994).
  CAS PubMed PubMed Central Google Scholar
• Weinert, T. A. & Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241, 317–322 (1988).
  CAS PubMed Google Scholar
• Edwards, R. J., Bentley, N. J. & Carr, A. M. A Rad3–Rad26 complex responds to DNA damage independently of other checkpoint proteins. Nature Cell Biol. 1, 393–398 (1999).
  CAS PubMed Google Scholar
• Lindsay, H. D. et al. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe. Genes Dev. 12, 382–395 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Martinho, R. G. et al. Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses. EMBO J. 17, 7239–7249 (1998).
  CAS PubMed PubMed Central Google Scholar
• Sidorova, J. M. & Breeden, L. L. Rad53-dependent phosphorylation of Swi6 and down-regulation of CLN1 and CLN2 transcription occur in response to DNA damage in Saccharomyces cerevisiae. Genes Dev. 11, 3032–3045 (1997).
  CAS PubMed PubMed Central Google Scholar
• Sanchez, Y. et al. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science 286, 1166–1171 (1999).
  Article CAS PubMed Google Scholar
• Little, J. B. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 146, 1064–1065 (1968).
  Google Scholar
• Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
  CAS PubMed Google Scholar
• Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304–6311 (1991).
  CAS PubMed Google Scholar
• Little, J. B. & Nove, J. Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure. Radiat. Res. 123, 87–92 (1990).
  CAS PubMed Google Scholar
• Weichselbaum, R. R., Epstein, J. & Little, J. B. In vitro radiosensitivity of human diploid fibroblasts derived from patients with unusual clinical responses to radiation. Radiology 121, 479–82 (1976).
  CAS PubMed Google Scholar
• Wahl, G. M., Linke, S. P., Paulson, T. G. & Huang, L. C. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29, 183–219 (1997).
  CAS PubMed Google Scholar
• Johnson, R. D. & Jasin, M. Double-strand-break-induced homologous recombination in mammalian cells. Biochem. Soc. Trans. 29, 196–201 (2001).
  CAS PubMed Google Scholar
• Maity, A., McKenna, W. G. & Muschel, R. J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31, 1–13 (1994).
  CAS PubMed Google Scholar
• Ward, J. F. Biochemistry of DNA lesions. Radiat. Res. Suppl. 8, S103–S111 (1985).
  CAS PubMed Google Scholar
• Little, J. B. Radiation carcinogenesis. Carcinogenesis 21, 397–404 (2000).
  CAS PubMed Google Scholar
• Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973–2983 (1998).
  CAS PubMed Google Scholar
• Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993).
  CAS PubMed Google Scholar
• Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847–849 (1993).
  CAS PubMed Google Scholar
• Stewart, Z. A. & Pietenpol, J. A. p53 signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243–263 (2001).
  CAS PubMed Google Scholar
• Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307–310 (2000).
  CAS PubMed Google Scholar
• Caelles, C., Helmberg, A. & Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220–223 (1994).
  CAS PubMed Google Scholar
• Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H. & Oren, M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9, 2170–2183 (1995).
  CAS PubMed Google Scholar
• Sabbatini, P., Lin, J., Levine, A. J. & White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9, 2184–2192 (1995).
  CAS PubMed Google Scholar
• Sansome, C., Zaika, A., Marchenko, N. D. & Moll, U. M. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett. 488, 110–115 (2001).
  CAS PubMed Google Scholar
• Marchenko, N. D., Zaika, A. & Moll, U. M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275, 16202–16212 (2000).
  CAS PubMed Google Scholar
• Rich, T., Allen, R. L. & Wyllie, A. H. Defying death after DNA damage. Nature 407, 777–783. (2000).
  CAS PubMed Google Scholar
• Shen, Y. & White, E. p53-dependent apoptosis pathways. Adv. Cancer Res. 82, 55–84 (2001).
  CAS PubMed Google Scholar
• Oda, K. et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102, 849–862 (2000).
  CAS PubMed Google Scholar
• Attardi, L. D. et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14, 704–718 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nakano, K. & Vousden, K. H. PUMA, a Novel Proapoptotic Gene, Is Induced by p53. Mol. Cell 7, 683–694 (2001).
  CAS PubMed Google Scholar
• Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673–682 (2001).
  CAS PubMed Google Scholar
• Moroni, M. C. et al. Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biol. 3, 552–558 (2001).
  CAS PubMed Google Scholar
• Jimenez, G. S. et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nature Genet. 26, 37–43 (2000).
  CAS PubMed Google Scholar
• Chao, C. et al. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19, 4967–4975 (2000).
  CAS PubMed PubMed Central Google Scholar
• el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
  CAS PubMed Google Scholar
• Deng, C., Zhang, P., Harper, J. W., Elledge, S. J. & Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
  CAS PubMed Google Scholar
• Hermeking, H. et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3–11 (1997).
  CAS PubMed Google Scholar
• Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. & Vogelstein, B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616–620 (1999).
  CAS PubMed Google Scholar
• Zhao, R. et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14, 981–993 (2000).
  CAS PubMed PubMed Central Google Scholar
• Murphy, M. et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13, 2490–2501 (1999).
  CAS PubMed PubMed Central Google Scholar
• Zhou, J., Ahn, J., Wilson, S. H. & Prives, C. A role for p53 in base excision repair. EMBO J. 20, 914–923 (2001).
  CAS PubMed PubMed Central Google Scholar
• Offer, H. et al. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene 20, 581–589 (2001).
  CAS PubMed Google Scholar
• Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999).
  CAS PubMed Google Scholar
• Ljungman, M. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2, 208–225 (2000).
  CAS PubMed PubMed Central Google Scholar
• Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031–36034 (1999).
  CAS PubMed Google Scholar
• Jimenez, G. S., Khan, S. H., Stommel, J. M. & Wahl, G. M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18, 7656–7665 (1999).
  CAS PubMed Google Scholar
• Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595–606 (1997).
  CAS PubMed Google Scholar
• Espinosa, J. M. & Emerson, B. M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8, 57–69 (2001).
  CAS PubMed Google Scholar
• McLure, K. G. & Lee, P. W. How p53 binds DNA as a tetramer. EMBO J. 17, 3342–3350 (1998).
  CAS PubMed PubMed Central Google Scholar
• Friedman, P. N., Chen, X., Bargonetti, J. & Prives, C. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl Acad. Sci. USA 90, 3319–3323 (1993).
  CAS PubMed PubMed Central Google Scholar
• Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660–1672. (1999).
  CAS PubMed PubMed Central Google Scholar
• Geyer, R. K., Yu, Z. K. & Maki, C. G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nature Cell Biol. 2, 569–573 (2000).
  CAS PubMed Google Scholar
• Boyd, S. D., Tsai, K. Y. & Jacks, T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nature Cell Biol. 2, 563–568 (2000).
  CAS PubMed Google Scholar
• Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25–27 (1997).
  CAS PubMed Google Scholar
• Honda, R. & Yasuda, H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473–1476 (2000).
  CAS PubMed Google Scholar
• Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945–8951 (2000).
  CAS PubMed Google Scholar
• Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997).
  CAS PubMed Google Scholar
• Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2 Nature 387, 299–303 (1997).
  CAS PubMed Google Scholar
• Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203–206 (1995).
  Google Scholar
• Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206–208 (1995).
  CAS PubMed Google Scholar
• Kussie, P. H. et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948–953 (1996).
  CAS PubMed Google Scholar
• Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857–860 (1993).
  CAS PubMed Google Scholar
• Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237–1245 (1992).
  CAS PubMed Google Scholar
• Chen, J., Marechal, V. & Levine, A. J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107–4114 (1993).
  CAS PubMed PubMed Central Google Scholar
• Fuchs, S. Y. et al. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12, 2658–2663 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kubbutat, M. H. & Vousden, K. H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell. Biol. 17, 460–468 (1997).
  CAS PubMed PubMed Central Google Scholar
• Maki, C. G. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2. J. Biol. Chem. 274, 16531–16535 (1999).
  CAS PubMed Google Scholar
• Zauberman, A., Barak, Y., Ragimov, N., Levy, N. & Oren, M. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J. 12, 2799–2808 (1993).
  CAS PubMed PubMed Central Google Scholar
• Rodriguez, M. S., Desterro, J. M., Lain, S., Lane, D. P. & Hay, R. T. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome- mediated degradation. Mol. Cell. Biol. 20, 8458–8467 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nakamura, S., Roth, J. A. & Mukhopadhyay, T. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol. Cell. Biol. 20, 9391–9398 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhu, Q., Yao, J., Wani, G., Wani, M. A. & Wani, A. A. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis. J. Biol. Chem. 276, 29695–29701 (2001).
  CAS PubMed Google Scholar
• Vassilev, A. et al. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol. Cell 2, 869–875 (1998).
  CAS PubMed Google Scholar
• Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19, 1202–1209 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gu, W., Shi, X. L. & Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature 387, 819–823 (1997).
  CAS PubMed Google Scholar
• Lai, Z. et al. Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. J. Biol. Chem. 276, 31357–31367 (2001).
  CAS PubMed Google Scholar
• Gu, J., Chen, D., Rosenblum, J., Rubin, R. M. & Yuan, Z. M. Identification of a sequence element from p53 that signals for Mdm2- targeted degradation. Mol. Cell. Biol. 20, 1243–1253 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zilfou, J. T., Hoffman, W. H., Sank, M., George, D. L. & Murphy, M. The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation. Mol. Cell. Biol. 21, 3974–3985 (2001).
  CAS PubMed PubMed Central Google Scholar
• Argentini, M., Barboule, N. & Wasylyk, B. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20, 1267–1275 (2001).
  CAS PubMed Google Scholar
• Parant, J. et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nature Genet. 29, 92–95 (2001).
  CAS PubMed Google Scholar
• Grossman, S. R. et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2, 405–415 (1998).
  CAS PubMed Google Scholar
• Crook, T., Nicholls, J. M., Brooks, L., O'Nions, J. & Allday, M. J. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19, 3439–3444 (2000).
  CAS PubMed Google Scholar
• De Laurenzi, V. & Melino, G. Evolution of functions within the p53/p63/p73 family. Ann. NY Acad. Sci. 926, 90–100 (2000).
  CAS PubMed Google Scholar
• Lohrum, M. A. & Vousden, K. H. Regulation and activation of p53 and its family members. Cell Death Differ. 6, 1162–1168 (1999).
  CAS PubMed Google Scholar
• Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067–1077 (2001).
  CAS PubMed PubMed Central Google Scholar
• Sherr, C. J. & Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94–99 (2000).
  CAS PubMed Google Scholar
• Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20–26 (1999).
  CAS PubMed Google Scholar
• Llanos, S., Clark, P. A., Rowe, J. & Peters, G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nature Cell Biol. 3, 445–452 (2001).
  CAS PubMed Google Scholar
• Honda, R. & Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22–27 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kamsler, A. et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61, 1849–1854 (2001).
  CAS PubMed Google Scholar
• Rotman, G. & Shiloh, Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays 19, 911–917 (1997).
  CAS PubMed Google Scholar
• Kamijo, T. et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res. 59, 2464–2469 (1999).
  CAS PubMed Google Scholar
• Gatei, M. et al. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid. Oncogene 20, 289–294 (2001).
  CAS PubMed Google Scholar
• Khan, S. H., Moritsugu, J. & Wahl, G. M. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl Acad. Sci. USA 97, 3266–3271 (2000).
  CAS PubMed PubMed Central Google Scholar
• Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649–659 (1997).
  CAS PubMed Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  CAS PubMed Google Scholar
• Artandi, S. E. & DePinho, R. A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46 (2000).
  CAS PubMed Google Scholar
• Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999).
  CAS PubMed Google Scholar
• Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321–1325 (1999).
  CAS PubMed Google Scholar
• Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71–77 (2001).
  CAS PubMed Google Scholar
• Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677–1679 (1998).
  CAS PubMed Google Scholar
• Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674–1677 (1998).
  CAS PubMed Google Scholar
• Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E. & Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041–5049. (1992).
  CAS PubMed PubMed Central Google Scholar
• Tibbetts, R. S. et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152–157 (1999).
  CAS PubMed PubMed Central Google Scholar
• Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R. & Brady, J. N. Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem. 273, 33048–33053 (1998).
  CAS PubMed Google Scholar
• Shieh, S. Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334 (1997).
  CAS PubMed Google Scholar
• Chao, C., Saito, S., Anderson, C. W., Appella, E. & Xu, Y. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc. Natl Acad. Sci. USA 97, 11936–11941 (2000).
  CAS PubMed PubMed Central Google Scholar
• Matsuoka, S. et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. USA 97, 10389–10394 (2000).
  CAS PubMed PubMed Central Google Scholar
• Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y. & Prives, C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289–300 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824–1827 (2000).
  CAS PubMed Google Scholar
• Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278–288 (2000).
  CAS PubMed PubMed Central Google Scholar
• Unger, T. et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805–1814 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chehab, N. H., Malikzay, A., Stavridi, E. S. & Halazonetis, T. D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl Acad. Sci. USA 96, 13777–13782 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528–2531 (1999).
  CAS PubMed Google Scholar
• Ashcroft, M., Kubbutat, M. H. & Vousden, K. H. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19, 1751–1758 (1999).
  CAS PubMed PubMed Central Google Scholar
• Waterman, M. J., Stavridi, E. S., Waterman, J. L. & Halazonetis, T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genet. 19, 175–178 (1998).
  CAS PubMed Google Scholar
• Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833–1844 (2001).
  CAS PubMed PubMed Central Google Scholar
• Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 (1998).
  CAS PubMed Google Scholar
• Dimri, G. P., Itahana, K., Acosta, M. & Campisi, J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 20, 273–285 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J. W., DeRyckere, D., Li, F. X., Wan, Y. Y. & DeGregori, J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ. 10, 829–838 (1999).
  CAS PubMed Google Scholar
• Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587–597 (1992).
  CAS PubMed Google Scholar
• Lu, X. & Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75, 765–778 (1993).
  CAS PubMed Google Scholar
• Linke, S. P. et al. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression. Oncogene 15, 337–345 (1997).
  CAS PubMed Google Scholar
• Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619–626 (1994).
  CAS PubMed Google Scholar
• Suzuki, K. et al. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening. Radiat. Res. 155, 248–253 (2001).
  CAS PubMed Google Scholar
• Gadbois, D. M., Bradbury, E. M. & Lehnert, B. E. Control of radiation-induced G1 arrest by cell-substratum interactions. Cancer Res. 57, 1151–1156 (1997).
  CAS PubMed Google Scholar
• DeSimone, J. N., Dolezalova, H., Redpath, J. L. & Stanbridge, E. J. Prolonged cell cycle arrest in irradiated human diploid skin fibroblasts: the role of nutrient deprivation. Radiat. Res. 153, 131–143 (2000).
  CAS PubMed Google Scholar
• Fenton, M., Barker, S., Kurz, D. J. & Erusalimsky, J. D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler. Thromb. Vasc. Biol. 21, 220–226 (2001).
  CAS PubMed Google Scholar
• Haks, M. C., Krimpenfort, P., van den Brakel, J. H. & Kruisbeek, A. M. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 11, 91–101 (1999).
  CAS PubMed Google Scholar
• Guidos, C. J. et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10, 2038–2054 (1996).
  CAS PubMed Google Scholar
• Vousden, K. H. p53: death star. Cell 103, 691–694 (2000).
  CAS PubMed Google Scholar
• Szak, S. T., Mays, D. & Pietenpol, J. A. Kinetics of p53 Binding to Promoter Sites in vivo. Mol. Cell. Biol. 21, 3375–3386 (2001).
  CAS PubMed PubMed Central Google Scholar
• Wang, Y. & Prives, C. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376, 88–91 (1995).
  CAS PubMed Google Scholar
• Kobayashi, T. et al. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ. 5, 584–591 (1998).
  CAS PubMed Google Scholar
• Ollmann, M. et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101, 91–101 (2000).
  CAS PubMed Google Scholar
• Brodsky, M. H. et al. Drosophila p53 binds a damage response element at the reaper locus. Cell 101, 103–113 (2000).
  CAS PubMed Google Scholar
• Jin, S. et al. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc. Natl Acad. Sci. USA 97, 7301–7306 (2000).
  CAS PubMed PubMed Central Google Scholar
• Brodsky, M. H., Sekelsky, J. J., Tsang, G., Hawley, R. S. & Rubin, G. M. mus304 encodes a novel DNA damage checkpoint protein required during Drosophila development. Genes Dev. 14, 666–678 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nordstrom, W. & Abrams, J. M. Guardian ancestry: fly p53 and damage-inducible apoptosis. Cell Death Differ. 7, 1035–1038 (2000).
  CAS PubMed Google Scholar
• Lev Bar-Or, R. et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc. Natl Acad. Sci. USA. 97, 11250–11255 (2000).
  CAS PubMed PubMed Central Google Scholar
• Alarcon, R., Koumenis, C., Geyer, R. K., Maki, C. G. & Giaccia, A. J. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 59, 6046–6051 (1999).
  CAS PubMed Google Scholar
• Koumenis, C. et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21, 1297–1310 (2001).
  CAS PubMed PubMed Central Google Scholar
• Graeber, T. G. et al. Hypoxia induces accumulation of p53 protein, but activation of a G1- phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264–6277 (1994).
  CAS PubMed PubMed Central Google Scholar
• Moulder, J. E. & Rockwell, S. Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev. 5, 313–341 (1987).
  CAS PubMed Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
  CAS PubMed Google Scholar
• de Stanchina, E. et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434–2442 (1998).
  CAS PubMed PubMed Central Google Scholar
• Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992).
  CAS PubMed Google Scholar
• Hermeking, H. & Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091–2093 (1994).
  CAS PubMed Google Scholar
• Denko, N. C., Giaccia, A. J., Stringer, J. R. & Stambrook, P. J. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc. Natl Acad. Sci. USA 91, 5124–5128 (1994).
  CAS PubMed PubMed Central Google Scholar
• Felsher, D. W. & Bishop, J. M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl Acad. Sci. USA 96, 3940–3944 (1999).
  CAS PubMed PubMed Central Google Scholar
• Fukasawa, K. & Vande Woude, G. F. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol. Cell. Biol. 17, 506–518 (1997).
  CAS PubMed PubMed Central Google Scholar
• Mai, S. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. Gene 148, 253–260 (1994).
  CAS PubMed Google Scholar
• Craig, A. L., Blaydes, J. P., Burch, L. R., Thompson, A. M. & Hupp, T. R. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation. Oncogene 18, 6305–6312 (1999).
  CAS PubMed Google Scholar
• Raveh, T., Droguett, G., Horwitz, M. S., DePinho, R. A. & Kimchi, A. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nature Cell Biol. 3, 1–7 (2001).
  CAS PubMed Google Scholar
• Finkel, T. Redox-dependent signal transduction. FEBS Lett. 476, 52–54 (2000).
  CAS PubMed Google Scholar
• Ries, S. et al. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103, 321–330 (2000).
  CAS PubMed Google Scholar
• Weitzman, J. B., Fiette, L., Matsuo, K. & Yaniv, M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6, 1109–1119 (2000).
  CAS PubMed Google Scholar
• Rothstein, R., Michel, B. & Gangloff, S. Replication fork pausing and recombination or “gimme a break”. Genes Dev. 14, 1–10 (2000).
  CAS PubMed Google Scholar
• Buschmann, T. et al. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21, 2743–2754 (2001).
  CAS PubMed PubMed Central Google Scholar